[Federal Register Volume 87, Number 38 (Friday, February 25, 2022)]
[Notices]
[Page 10820]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04064]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-974]


Bulk Manufacturer of Controlled Substances Application: Cedarburg 
Pharmaceuticals

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cedarburg Pharmaceuticals has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2022.

ADDRESSES: DEA requires that all comments be submitted electronically 
through the Federal eRulemaking Portal, which provides the ability to 
type short comments directly into the comment field on the web page or 
attach a file for lengthier comments. Please go to http://www.regulations.gov and follow the online instructions at that site for 
submitting comments. Upon submission of your comment, you will receive 
a Comment Tracking Number. Please be aware that submitted comments are 
not instantaneously available for public view on http://www.regulations.gov. If you have received a Comment Tracking Number, 
your comment has been successfully submitted and there is no need to 
resubmit the same comment.''

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on August 27, 2021, Cedarburg Pharmaceuticals, 870 
Badger Circle, Grafton, Wisconsin 53024-0000, applied to be registered 
as a bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Lysergic Acid Diethylamide.............     7315  I
Tetrahydrocannabinols..................     7370  I
4-Bromo-2,5-Dimethoxyphenethylamine....     7392  I
3,4-Methylenediocyamphetamine..........     7400  I
3.4-Methylenedioxymethamphetamine......     7405  I
5-Methoxy-N-N-dimethltryptamine........     7431  I
Dimethyltryptamine.....................     7435  I
Psilocybin.............................     7437  I
Psilocyn...............................     7438  I
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
4-Anilino-N-Phenethyl-4-Piperidine          8333  II
 (ANPP).
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. In reference to the drug code 7370 (Tetrahydrocannabinols), 
the company plans to bulk manufacture as synthetic. No other activity 
for this drug code is authorized for this registration.

Matthew J. Strait,
Deputy Assistant Administrator.
[FR Doc. 2022-04064 Filed 2-24-22; 8:45 am]
BILLING CODE 4410-09-P